BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37298667)

  • 1. Synergy by Ristocetin and CXCL12 in Human Platelet Activation: Divergent Regulation by Rho/Rho-Kinase and Rac.
    Enomoto Y; Onuma T; Hori T; Tanabe K; Ueda K; Mizutani D; Doi T; Matsushima-Nishiwaki R; Ogura S; Iida H; Iwama T; Kozawa O; Tokuda H
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Rac in thromboxane A2‑induced human platelet activation: regulation of sCD40 ligand release and PDGF‑AB secretion.
    Kageyama Y; Doi T; Matsushima-Nishiwaki R; Iida Y; Akamatsu S; Kondo A; Kuroyanagi G; Yamamoto N; Mizutani J; Otsuka T; Tokuda H; Iida H; Kozawa O; Ogura S
    Mol Med Rep; 2014 Jul; 10(1):107-12. PubMed ID: 24737161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of collagen and CXCL12 in the low doses on human platelet activation.
    Nakashima D; Onuma T; Tanabe K; Kito Y; Uematsu K; Mizutani D; Enomoto Y; Tsujimoto M; Doi T; Matsushima-Nishiwaki R; Tokuda H; Ogura S; Iwama T; Kozawa O; Iida H
    PLoS One; 2020; 15(10):e0241139. PubMed ID: 33119719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antithrombin III on glycoprotein Ib/IX/V activation in human platelets: suppression of thromboxane A2 generation.
    Doi T; Tokuda H; Matsushima-Nishiwaki R; Cuong NT; Kageyama Y; Iida Y; Kondo A; Akamatsu S; Otsuka T; Iida H; Kozawa O; Ogura S
    Prostaglandins Leukot Essent Fatty Acids; 2012; 87(2-3):57-62. PubMed ID: 22819492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.
    Delaney MK; Liu J; Zheng Y; Berndt MC; Du X
    Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2761-8. PubMed ID: 22995516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rac regulates collagen-induced HSP27 phosphorylation via p44/p42 MAP kinase in human platelets.
    Kageyama Y; Doi T; Akamatsu S; Kuroyanagi G; Kondo A; Mizutani J; Otsuka T; Tokuda H; Kozawa O; Ogura S
    Int J Mol Med; 2013 Oct; 32(4):813-8. PubMed ID: 23900529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho-kinase regulates human platelet activation induced by thromboxane A2 independently of p38 MAP kinase.
    Iida Y; Doi T; Tokuda H; Matsushima-Nishiwaki R; Tsujimoto M; Kuroyanagi G; Yamamoto N; Enomoto Y; Tanabe K; Otsuka T; Iwama T; Ogura S; Kozawa O; Iida H
    Prostaglandins Leukot Essent Fatty Acids; 2015 Mar; 94():73-81. PubMed ID: 25500336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for p38 MAP kinase in platelet activation by von Willebrand factor.
    Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M
    Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. αB-crystallin reduces ristocetin‑induced soluble CD40 ligand release in human platelets: suppression of thromboxane A2 generation.
    Tsujimoto M; Doi T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Iida Y; Enomoto Y; Iida H; Ogura S; Otsuka T; Tokuda H; Kozawa O; Iwama T
    Mol Med Rep; 2015 Jul; 12(1):357-62. PubMed ID: 25760062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets.
    Garcia A; Quinton TM; Dorsam RT; Kunapuli SP
    Blood; 2005 Nov; 106(10):3410-4. PubMed ID: 16020504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tramadol regulates the activation of human platelets via Rac but not Rho/Rho-kinase.
    Iida H; Onuma T; Nakashima D; Mizutani D; Hori T; Ueda K; Hioki T; Kim W; Enomoto Y; Doi T; Matsushima-Nishiwaki R; Yamaguchi S; Tachi J; Tanabe K; Ogura S; Iwama T; Kozawa O; Tokuda H
    PLoS One; 2023; 18(1):e0279011. PubMed ID: 36638092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies.
    Frontroth JP; Favaloro EJ
    Methods Mol Biol; 2017; 1646():473-494. PubMed ID: 28804849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein tyrosine phosphorylation in human platelets induced by interaction between glycoprotein Ib and von Willebrand factor.
    Ozaki Y; Satoh K; Yatomi Y; Miura S; Fujimura Y; Kume S
    Biochim Biophys Acta; 1995 Apr; 1243(3):482-8. PubMed ID: 7537105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane A(2) promotes soluble CD40 ligand release from human platelets.
    Enomoto Y; Adachi S; Matsushima-Nishiwaki R; Doi T; Niwa M; Akamatsu S; Tokuda H; Ogura S; Yoshimura S; Iwama T; Kozawa O
    Atherosclerosis; 2010 Apr; 209(2):415-21. PubMed ID: 19932480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac Regulates the TRAP-Induced Release of Phosphorylated-HSP27 from Human Platelets via p38 MAP Kinase but Not JNK.
    Uematsu K; Enomoto Y; Onuma T; Tsujimoto M; Doi T; Matsushima-Nishiwaki R; Tokuda H; Ogura S; Iida H; Kozawa O; Iwama T
    Cell Physiol Biochem; 2018; 49(4):1523-1538. PubMed ID: 30212812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Direct Thrombin Inhibitors Dabigatran and Lepirudin Inhibit GPIbα-Mediated Platelet Aggregation.
    Trabold K; Makhoul S; Gambaryan S; van Ryn J; Walter U; Jurk K
    Thromb Haemost; 2019 Jun; 119(6):916-929. PubMed ID: 31005062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
    Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.